Acquisition of a Branded Pharmaceutical Company in India

Company Overview

An Indian integrated pharmaceutical company focused on branded pharmaceutical formulations in the Indian domestic market. The company manufactures, markets, and sells pharmaceutical products through a strong sales and distribution network.

Business Model:

The Company operates an integrated pharmaceutical business model focused on:

• Development & Manufacturing: Creating unique formulations with patented packaging features
• Established Brand Portfolio: 12 brands with 32 SKUs, including 3 brands each generating over €1.09 million
• Marketing & Sales: Engaging directly with doctors through a dedicated sales force to drive prescriptions
• Distribution: Operating a multi-tier distribution network with C&F agents, stockists, and sub-stockists to ensure product availability
• Brand Building: Creating and nurturing pharmaceutical brands in niche therapeutic segments
• Doctor Engagement: Regular in-clinic promotion, continuous medical education activities, and participation in conferences

Transaction

The promoters are seeking to divest their stake in favor of a strategic investor who can drive the next phase of growth for the business.

Investor Rationale

• Strong Financial Performance: Revenue of €4.91 million in FY 2024-25 (15.4% growth), EBITDA of €0.81 million (16.4% margin), and Net Profit of €0.44 million (9% margin)

• Niche Therapeutic Focus: Leading positions in Neuropathy, Diabetes Complications, Cardiovascular Disease, Pain Management, and Wound Care

• Geographic Reach: Established operations in 13 states across South, East, North East & Central India

• Robust Sales Infrastructure: 185+ sales personnel covering ~19,000 doctors across 7 specialties

• Extensive Distribution Network: 8 C&F agents, 305+ stockists, and ~15,000 retailers

• Differentiated Products: Unique product features including patented packaging and exclusive formulations

• Growth Platform: Fully established operation with immediate market access and experienced sales team

• Market Growth: Indian branded formulations market expected to grow at 11% CAGR over next five years